Stock P09 PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Pacific Biosciences of California, Inc. Börse Stuttgart

Equities

P09

US69404D1081

Real-time Estimate Tradegate
Other stock markets
 07:00:17 2024-07-01 EDT 		5-day change 1st Jan Change
1.27 EUR +0.78% Intraday chart for Pacific Biosciences of California, Inc. -8.16% -86.31%
06-27 PacBio, Form Bio Team Up to Launch Initiatives to Unify AAV Gene Therapy Industry MT
06-27 Form Bio and Pacbio Announce Collaboration to Launch New Resources Set to Transform Aav Design and Analysis Best Practices CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
PacBio, Form Bio Team Up to Launch Initiatives to Unify AAV Gene Therapy Industry
MT
Form Bio and Pacbio Announce Collaboration to Launch New Resources Set to Transform Aav Design and Analysis Best Practices
CI
PacBio and International Research Consortium CoLoRS Announce Release of First-Ever HiFi Long-Read Variant Database
PR
PacBio and International Research Consortium Colors Announce Release of First-Ever HiFi Long-Read Variant Database
CI
Jefferies & Co Initiates Coverage on Pacific Biosciences of California With Buy Rating, $4 Price Target
MT
Pacific Biosciences, Ambry Genetics Selected to Sequence up to 7,000 Human Genomes
MT
Morgan Stanley Adjusts Price Target on Pacific Biosciences of California to $4 From $10, Maintains Equal-Weight Rating
MT
Ambry Genetics and PacBio Announce Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases
PR
Ambry Genetics and PacBio Announces Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases
CI
Piper Sandler Adjusts Price Target on Pacific Biosciences of California to $2 From $6.50, Maintains Neutral Rating
MT
Pacific Biosciences of California : PacBio Q1 2024 Earnings Presentation
PU
Pacific Biosciences: Q1 Earnings Snapshot
AQ
Transcript : Pacific Biosciences of California, Inc., Q1 2024 Earnings Call, May 09, 2024
Earnings Flash (PACB) PACIFIC BIOSCIENCES OF CALIFORNIA Reports Q1 Revenue $38.8M
MT
Pacific Biosciences of California, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
PacBio Announces First Quarter 2024 Financial Results
PR
NewBiologix Launches Next-Generation Sequencing and Optical Mapping Platform to Drive the Next Wave of Biopharmaceutical Discoveries
AQ
JPMorgan Downgrades Pacific Biosciences of California to Neutral From Overweight
MT
Scotiabank Adjusts Pacific Biosciences of California's Price Target to $8 From $15, Maintains Sector Outperform Rating
MT
Goldman Sachs Downgrades Pacific Biosciences of California to Neutral From Buy, Adjusts Price Target to $2.50 From $7
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PACB Stock
  4. P09 Stock
  5. News Pacific Biosciences of California, Inc.